Celgene, Dendreon Lead Short Interest Trend In Biotechs (BMRN, CELG, DNDN)

By: Benzinga
The number of shares sold short in leading biotech and emerging pharmaceutical companies mostly declined between the December 13 and December 31 settlement dates. BioMarin Pharmaceutical (NASDAQ: BMRN ), Celgene (NASDAQ: CELG ) and Dendreon (NASDAQ: DNDN ) led that trend. Short sellers also shied away from Biogen
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.